Nascent Biotech

Nascent Biotech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nascent Biotech (NBIO) as of Oct 20, 2026 is -2.16 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -460,000.00 USD — a change of 369.57% (lower).

EBITDA

-2.16 MUSD

YoY

369.57%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nascent Biotech is 2023 -2.16 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nascent Biotech was 2022 -460,000.00 USD. It decreases by 369.57% lower compared to the previous year.

The Nascent Biotech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2016
-5.44 M USD
Jan 1, 2017
950,000.00 USD
Jan 1, 2018
-2.22 M USD
Jan 1, 2019
-1.37 M USD
Jan 1, 2020
-3.45 M USD
Jan 1, 2021
-1.40 M USD
Jan 1, 2022
-460,000.00 USD
Jan 1, 2023
-2.16 M USD
The Nascent Biotech EBITDA history
YEAREBITDAYoY
-2.16 MUSD+369.57%
-460,000.00USD-67.14%
-1.40 MUSD-59.42%
-3.45 MUSD+151.82%
-1.37 MUSD-38.29%
-2.22 MUSD-333.68%
950,000.00USD-117.46%
-5.44 MUSD+154.21%
-2.14 MUSD+268.97%
-580,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Nascent Biotech Stock analysis

What does Nascent Biotech do? Nascent Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nascent Biotech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nascent Biotech is -2.16 M USD in 2023.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Nascent Biotech changed from -460,000.00 USD to -2.16 M USD, representing a 369.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Nascent Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Nascent Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Nascent Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Nascent Biotech